News & Updates
Showing Respirology articles
Showing
Long COVID profoundly affects patients' QoL
In a functional assessment of post-COVID long-term sequelae, individuals suffering from long COVID (having at least one symptom of post-COVID-19 syndrome) had poorer quality of life (QoL) than those unaffected by the syndrome.
COVID-19 vaccine perception poor among SG drivers
A substantial proportion of transport drivers in Singapore had poor vaccine perception, were hesitant to receive the COVID-19 vaccine, and were unwilling to receive the third dose (booster shot) despite the high vaccination coverage in the city-state, a cross-sectional pilot study reports.
Valaciclovir suppresses Epstein-Barr virus in COPD patients
Treatment with valaciclovir leads to efficacious suppression of Epstein-Barr virus (EBV), having the potential to reduce the sputum inflammatory cell infiltrate, in patients with chronic obstructive pulmonary disease (COPD), according to data from the EViSCO study.
Long COVID: What are the risk and protective factors?
A population-based, multicentre study finds female gender, transportation-, logistics- or discipline-related occupation, living with domestic workers, smoking, poor or very poor self-perceived health status, ≥3 chronic diseases, chronic medication use, and critical severity of COVID-19 to be associated with severe long COVID, while prior receipt of ≥2 doses of COVID-19 vaccines serves as a protective factor.
Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen
In a systematic review and individual patient data meta-analysis, the broad-spectrum antiviral agent remdesivir reduced mortality in adult patients hospitalized for COVID-19 who did not require oxygen support or only required low-flow supplementation when the need for oxygen arose.